Cargando…
Serum Beta-2 Microglobulin: A Possible Biomarker for Atrial Fibrillation
BACKGROUND: Atrial fibrillation (AF) is the most common persistent arrhythmia that can cause complications (including stroke). Therefore, its diagnosis and treatment require increased attention. Although beta-2 microglobulin (β2-MG) is a novel marker of cardiovascular disease, its role in AF has not...
Autores principales: | Zhang, Bangying, Chen, Xinpei, Mu, Xiaofeng, Liu, Enzhao, Liu, Tong, Xu, Gang, Bao, Qiankun, Li, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619805/ https://www.ncbi.nlm.nih.gov/pubmed/34803158 http://dx.doi.org/10.12659/MSM.932813 |
Ejemplares similares
-
Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
por: Zhou, Xue, et al.
Publicado: (2020) -
Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial
por: Zhao, Zhiqiang, et al.
Publicado: (2020) -
Association of beta-2-microglobulin with cardiovascular and all-cause mortality in the general and non-CKD population
por: Fang, Hang, et al.
Publicado: (2023) -
Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
por: Zhang, Nixiao, et al.
Publicado: (2018) -
Serum Beta 2-Microglobulin/Cystatin C Index: A Useful Biomarker in Lupus Nephritis?
por: Madureira Silva, Marcus Vinicius, et al.
Publicado: (2012)